![Radiomics diagnosed histopathological growth pattern in prediction of response and 1-year progression free survival for colorectal liver metastases patients treated with bevacizumab containing chemotherapy - European Journal of Radiology Radiomics diagnosed histopathological growth pattern in prediction of response and 1-year progression free survival for colorectal liver metastases patients treated with bevacizumab containing chemotherapy - European Journal of Radiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/0a094090-f446-492e-ae31-1b292c2a41ae/gr1_lrg.jpg)
Radiomics diagnosed histopathological growth pattern in prediction of response and 1-year progression free survival for colorectal liver metastases patients treated with bevacizumab containing chemotherapy - European Journal of Radiology
![Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy | Future Oncology Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy | Future Oncology](https://www.futuremedicine.com/cms/10.2217/fon.11.32/asset/images/medium/figure1.gif)
Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy | Future Oncology
![Liver transplantation for secondary liver tumours: The difficult balance between survival and recurrence - Journal of Hepatology Liver transplantation for secondary liver tumours: The difficult balance between survival and recurrence - Journal of Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e8f411ea-839e-444e-9d35-d905215aa01b/gr1_lrg.jpg)
Liver transplantation for secondary liver tumours: The difficult balance between survival and recurrence - Journal of Hepatology
![The clinical value of carcinoembryonic antigen for tumor metastasis assessment in lung cancer [PeerJ] The clinical value of carcinoembryonic antigen for tumor metastasis assessment in lung cancer [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2019/7433/1/fig-3-full.png)
The clinical value of carcinoembryonic antigen for tumor metastasis assessment in lung cancer [PeerJ]
![Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients](https://www.spandidos-publications.com/article_images/ol/14/6/ol-14-06-7549-g00.jpg)
Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients
![The clinical value of carcinoembryonic antigen for tumor metastasis assessment in lung cancer [PeerJ] The clinical value of carcinoembryonic antigen for tumor metastasis assessment in lung cancer [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2019/7433/1/fig-1-full.png)
The clinical value of carcinoembryonic antigen for tumor metastasis assessment in lung cancer [PeerJ]
![Mode of progression after radioembolization in patients with colorectal cancer liver metastases | EJNMMI Research | Full Text Mode of progression after radioembolization in patients with colorectal cancer liver metastases | EJNMMI Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13550-020-00697-z/MediaObjects/13550_2020_697_Fig3_HTML.png)
Mode of progression after radioembolization in patients with colorectal cancer liver metastases | EJNMMI Research | Full Text
![Cancers | Free Full-Text | Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know | HTML Cancers | Free Full-Text | Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know | HTML](https://www.mdpi.com/cancers/cancers-14-01493/article_deploy/html/images/cancers-14-01493-g001.png)
Cancers | Free Full-Text | Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know | HTML
![CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies | British Journal of Cancer CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41416-021-01483-x/MediaObjects/41416_2021_1483_Fig3_HTML.png)
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies | British Journal of Cancer
![A blood tumor marker combination assay produces high sensitivity and specificity for cancer according to the natural history - Kobayashi - 2018 - Cancer Medicine - Wiley Online Library A blood tumor marker combination assay produces high sensitivity and specificity for cancer according to the natural history - Kobayashi - 2018 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9a873d30-ab93-411f-ba8c-d780e23a68b9/cam41275-fig-0001-m.jpg)
A blood tumor marker combination assay produces high sensitivity and specificity for cancer according to the natural history - Kobayashi - 2018 - Cancer Medicine - Wiley Online Library
![PDF) THE RELATIONSHIP BETWEEN TRIPLE TUMOR MARKER (CEA, CA 19-9, AND CA 125) AND COLORECTAL CANCER METASTASES AT MAKASSAR, INDONESIA PDF) THE RELATIONSHIP BETWEEN TRIPLE TUMOR MARKER (CEA, CA 19-9, AND CA 125) AND COLORECTAL CANCER METASTASES AT MAKASSAR, INDONESIA](https://i1.rgstatic.net/publication/342286143_THE_RELATIONSHIP_BETWEEN_TRIPLE_TUMOR_MARKER_CEA_CA_19-9_AND_CA_125_AND_COLORECTAL_CANCER_METASTASES_AT_MAKASSAR_INDONESIA/links/5f5e18a492851c07896355c1/largepreview.png)
PDF) THE RELATIONSHIP BETWEEN TRIPLE TUMOR MARKER (CEA, CA 19-9, AND CA 125) AND COLORECTAL CANCER METASTASES AT MAKASSAR, INDONESIA
![Significance of serum carcinoembryonic antigen in metastatic breast cancer patients: A prospective study Significance of serum carcinoembryonic antigen in metastatic breast cancer patients: A prospective study](https://f6publishing.blob.core.windows.net/6d096f57-fd4f-41e5-97d8-4f36cf329351/WJCO-13-529-g002.png)
Significance of serum carcinoembryonic antigen in metastatic breast cancer patients: A prospective study
![The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients | BMC Cancer | Full Text The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-018-4987-0/MediaObjects/12885_2018_4987_Fig2_HTML.png)
The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients | BMC Cancer | Full Text
![Colorectal cancer-associated fibroblasts promote metastasis by up-regulating LRG1 through stromal IL-6/STAT3 signaling | Cell Death & Disease Colorectal cancer-associated fibroblasts promote metastasis by up-regulating LRG1 through stromal IL-6/STAT3 signaling | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-021-04461-6/MediaObjects/41419_2021_4461_Fig1_HTML.png)
Colorectal cancer-associated fibroblasts promote metastasis by up-regulating LRG1 through stromal IL-6/STAT3 signaling | Cell Death & Disease
![Prediction of progressive disease using tumor markers in metastatic breast cancer patients without target lesions in first-line chemotherapy - Annals of Oncology Prediction of progressive disease using tumor markers in metastatic breast cancer patients without target lesions in first-line chemotherapy - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/0aff01f7-3322-43bd-8f1e-8005b32a7485/gr1_lrg.jpg)
Prediction of progressive disease using tumor markers in metastatic breast cancer patients without target lesions in first-line chemotherapy - Annals of Oncology
![CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-021-01431-9/MediaObjects/41416_2021_1431_Fig1_HTML.png)
CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer
![The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients | BMC Cancer | Full Text The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-018-4987-0/MediaObjects/12885_2018_4987_Fig1_HTML.png)